How could a new treatment, given previously under expanded access, successfully treat a serious disease of the eye?

How could a new treatment, given previously under expanded access, successfully treat a serious disease of the eye?

A treatment for neurotrophic keratitis, initially given under expanded access, has been approved for use in European countries. The treatment, a genetically engineered nerve growth factor, has been shown to heal the corneas of affected patients, including children. http://bit.ly/2yjsygw

Comments

comments

2017-11-07T12:20:58+00:00 November 7, 2017|General|